(Q36317151)

13 August 2017

1 reference

title

Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens (English)

1 reference

13 August 2017

J M Boulter

1

1 reference

PubMed ID

16297157

13 August 2017

B K Jakobsen

series ordinal

2

1 reference

13 August 2017

1 December 2005

1 reference

Clinical and Experimental Immunology

13 August 2017

1 reference

13 August 2017

142

1 reference

13 August 2017

3

1 reference

13 August 2017

454-460

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Phage antibodies: filamentous phage displaying antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Making antibody fragments using phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Ligand recognition by alpha beta T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Molecular interactions mediating T cell antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Binding properties and solubility of single-chain T cell receptors expressed in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Stable, soluble T-cell receptor molecules for crystallization and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Structural and kinetic basis for heightened immunogenicity of T cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Affinity of the monoclonal antibody M1 directed against the FLAG peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Directed evolution of a stable scaffold for T-cell receptor engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

TCRs with high affinity for foreign pMHC show self-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Directed evolution of human T-cell receptors with picomolar affinities by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Finding a place for tumor-specific T cells in targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Prospects for immunotherapy of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Identification of the antigenic epitopes in staphylococcal enterotoxins A and E and design of a superantigen for human cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein x anti-CD3 diabody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Antibody-cytokine fusion proteins: innovative weapons in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Functional three-domain single-chain T-cell receptors

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Development of human anti-murine antibody (HAMA) response in patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Humanization of an anti-p185HER2 antibody for human cancer therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Display of functional alphabeta single-chain T-cell receptor molecules on the surface of bacteriophage

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalyti

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809535

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

21 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02929.X

The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

12 December 2020

Interleukin-13 prevents autoimmune diabetes in NOD mice

1 reference

12 December 2020

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach

1 reference

12 December 2020

Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules

1 reference

12 December 2020

Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation

1 reference

12 December 2020

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha

1 reference

12 December 2020

A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02929.X

Identifiers

DOI

1 reference

13 August 2017

0 references

1 reference

PubMed ID

16297157